Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Boĭtsov

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Terapevticheskii Arkhiv|November 23, 2013
[Endothelial NO synthase and connexin 37 gene polymorphisms as a risk factor for myocardial infarction in subjects without a history of coronary artery disease]A V Balatskiĭ, E Yu Andreenko, L M Samokhodskaya, et al.
Terapevticheskii Arkhiv|October 24, 2012
[Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: two-year follow-up results]S Zh Urazalina, S A Boĭtsov, T V Balakhonova, et al.
Klinicheskaia Meditsina|January 13, 2006
[Effect of respiratory infections on the clinical course of coronary artery disease]Iu V Lobzin, S A Boĭtsov, A E Filippov, et al.
Terapevticheskii Arkhiv|April 30, 2003
[Use of metaiodobenzylguanidine for assessing status of ends of myocardial sympathetic nerves in myocardium of patients with bronchial asthma]S A Boĭtsov, A N Kuchmin, I V Beozertseva, et al.
Klinicheskaia Meditsina|October 29, 2013
[Arterial stiffness and blood levels of glycation end-products in patients with arterial hypertension and carotid atherosclerosis]T V Vakhovskaia, T V Balakhonova, M M Luk'ianov, et al.
Kardiologiia|July 31, 2012
[The contribution of parameters of subclinical artery wall damage in the evaluation of cardiovascular risk]S Zh Urazalina, A N Rogoza, T V Balakhonova, et al.
Klinicheskaia Meditsina|March 15, 2011
[Detectability of acute forms of coronary heart disease in real clinical practice]S A Boĭtsov, N N Nikulina, S S Iakushin, et al.
Terapevticheskii Arkhiv|December 8, 2011
[Relationship between concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of the arterial wall in patients with low and moderate risk by SCORE scale]S Zh Urazalina, V N Titov, T N Vlasik, et al.
Kardiologiia|February 14, 2015
[Prevalence of cardiiovascular risk factors in Russian population of patients with arterial hypertension]I E Chazova, Iu V Zhernakova, E V Oshchepkova, et al.
Terapevticheskii Arkhiv|June 4, 2004
[Efficacy of cytoprotective agent Mexicor in urgent cardiology]A P Golikov, V P Mikhin, S A Boĭtsov, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Terapevticheskii Arkhiv|November 23, 2013
[Endothelial NO synthase and connexin 37 gene polymorphisms as a risk factor for myocardial infarction in subjects without a history of coronary artery disease]A V Balatskiĭ, E Yu Andreenko, L M Samokhodskaya, et al.
Terapevticheskii Arkhiv|October 24, 2012
[Trends in the risk factors and signs of subclinical atherosclerosis in subjects at low and moderate risk according to the SCORE scale in different medical management tactics: two-year follow-up results]S Zh Urazalina, S A Boĭtsov, T V Balakhonova, et al.
Klinicheskaia Meditsina|January 13, 2006
[Effect of respiratory infections on the clinical course of coronary artery disease]Iu V Lobzin, S A Boĭtsov, A E Filippov, et al.
Terapevticheskii Arkhiv|April 30, 2003
[Use of metaiodobenzylguanidine for assessing status of ends of myocardial sympathetic nerves in myocardium of patients with bronchial asthma]S A Boĭtsov, A N Kuchmin, I V Beozertseva, et al.
Klinicheskaia Meditsina|October 29, 2013
[Arterial stiffness and blood levels of glycation end-products in patients with arterial hypertension and carotid atherosclerosis]T V Vakhovskaia, T V Balakhonova, M M Luk'ianov, et al.
Kardiologiia|July 31, 2012
[The contribution of parameters of subclinical artery wall damage in the evaluation of cardiovascular risk]S Zh Urazalina, A N Rogoza, T V Balakhonova, et al.
Klinicheskaia Meditsina|March 15, 2011
[Detectability of acute forms of coronary heart disease in real clinical practice]S A Boĭtsov, N N Nikulina, S S Iakushin, et al.
Terapevticheskii Arkhiv|December 8, 2011
[Relationship between concentration of lipoprotein-associated secretory phospholipase A2 and markers of subclinical atherosclerotic lesion of the arterial wall in patients with low and moderate risk by SCORE scale]S Zh Urazalina, V N Titov, T N Vlasik, et al.
Kardiologiia|February 14, 2015
[Prevalence of cardiiovascular risk factors in Russian population of patients with arterial hypertension]I E Chazova, Iu V Zhernakova, E V Oshchepkova, et al.
Terapevticheskii Arkhiv|June 4, 2004
[Efficacy of cytoprotective agent Mexicor in urgent cardiology]A P Golikov, V P Mikhin, S A Boĭtsov, et al.
Pageof 4